Pet Anxiety and Calming Products Market Forecasts to 2034 - Global Analysis By Product Type, Pet Type, Distribution Channel, and By Geography

According to Stratistics MRC, the Global Pet Anxiety and Calming Products Market is accounted for $18.0 billion in 2026 and is expected to reach $24.2 billion by 2034 growing at a CAGR of 3.8% during the forecast period. Pet anxiety and calming products are solutions designed to reduce stress, anxiety, and behavioral issues in companion animals, improving their well-being and quality of life. The market encompasses product types including calming supplements, pheromone-based products, calming wearables, calming toys, topical calming products, and other calming products. These products serve dogs, cats, and other pets through veterinary clinics and hospitals, pet specialty stores, supermarkets and mass retailers, online retail, and other distribution channels. Growing awareness of pet mental health, increasing pet humanization, and rising prevalence of anxiety-related conditions in pets are key drivers of market expansion.

Market Dynamics:

Driver:

Growing awareness of pet mental health and anxiety issues

The increasing recognition of mental health issues in companion animals and the impact of anxiety on pet well-being is a primary driver for the pet anxiety and calming products market. Pet owners are increasingly aware of signs of stress and anxiety in their animals. Behavioral issues including separation anxiety and noise phobias affect many pets. The humanization of pets has led to greater focus on emotional well-being. As awareness of pet mental health grows, demand for calming products expands, supporting sustained market growth.

Restraint:

Limited efficacy evidence and skepticism

Limited scientific evidence for some calming products and consumer skepticism about efficacy represent a major restraint for the market. Not all products have robust clinical evidence. Some consumers may be skeptical of natural calming remedies. Efficacy can vary between individual animals. These evidence and skepticism challenges may constrain market growth for certain product categories.

Opportunity:

Innovation in natural and clinically validated calming ingredients

Continuous innovation in natural and clinically validated calming ingredients presents significant opportunities for market expansion. Ingredients including L-theanine, chamomile, and CBD are gaining popularity. Clinical studies supporting efficacy are increasing. Novel delivery formats improve convenience. As product quality and evidence improve, innovative calming products capture growing market share.

Threat:

Competition from behavioral training and veterinary medications

Competition from behavioral training approaches and prescription veterinary medications poses significant threats to the pet anxiety and calming products market. Training may address behavioral issues without products. Prescription medications may be preferred for severe anxiety. These alternatives may limit market growth for over-the-counter calming products.

Covid-19 Impact:

The COVID-19 pandemic accelerated pet anxiety and calming products market growth as pets experienced routine disruptions and owners returned to work. Separation anxiety increased as owners returned to offices. Awareness of pet mental health grew. E-commerce sales of calming products expanded. Post-pandemic, continued focus on pet well-being has supported market growth.

The Calming Supplements segment is expected to be the largest during the forecast period

The Calming Supplements segment is expected to account for the largest market share during the forecast period, driven by their accessibility, variety of formats, and growing consumer preference for natural calming solutions. Calming supplements including chews, tablets, and powders offer convenient options for managing pet anxiety. The segment benefits from expanding product availability and consumer awareness. As the most accessible calming product category, supplements maintain the largest product type segment share.

The Dogs segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the Dogs segment is predicted to witness the highest growth rate, fueled by the large dog population, high prevalence of anxiety in dogs, and growing owner awareness of canine mental health. Dogs commonly experience separation anxiety, noise phobias, and situational stress. The segment benefits from extensive product development for dogs. As dog ownership and anxiety awareness grow, this pet type delivers the fastest segment growth.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, supported by high pet ownership, strong awareness of pet mental health, and established product availability. The United States leads regional growth with substantial consumer spending on pet calming products. High awareness of pet anxiety issues drives demand. Well-established retail and e-commerce channels support market accessibility. With high spending and awareness, North America maintains its dominant market position.

Region with highest CAGR:

Over the forecast period, the Europe region is anticipated to exhibit the highest CAGR, driven by increasing pet ownership, growing awareness of pet mental health, and expanding product availability across European countries. European pet owners are increasingly focused on pet well-being. Product innovation and availability are expanding. As awareness grows, Europe delivers the fastest pet anxiety and calming products market growth globally.

Key players in the market

Some of the key players in Pet Anxiety and Calming Products Market include Nestle Purina PetCare, Mars, Incorporated, Zoetis Inc., Virbac S.A., Elanco Animal Health Incorporated, Ceva Sante Animale, PetIQ, LLC, Zesty Paws, PetHonesty, Vetoquinol S.A., NaturVet, THUNDERWORKS, Pet Remedy Ltd., Feliway, and PetSafe Brands.

Key Developments:

In September 2026, Ceva Animal Health expanded its welfare initiative with Cats Protection across the United Kingdom, linking FELIWAY Optimum sales directly to sheltering and behavioral enrichment programs for surrendered cats showing severe anxiety.

In July 2026, Vetoquinol USA officially introduced Zylkene Plus across the United States, expanding its alpha-casozepine-based calming line with a dual-active formula designed for longer-term management of chronic environmental stress and behavioral anxiety in dogs and cats.

In February 2026, Nestle Purina PetCare convened global veterinary behaviorists and animal welfare scientists at the Purina Pro Plan Calming Care Symposium, presenting clinical research on modulating the canine gut-brain axis and highlighting regulatory milestones for the BL999 probiotic strain.

In January 2026, Elanco secured USDA approval for TruCan Ultra B (Oral), collaborating with the Fear Free movement to market low-volume, low-stress preventive administration formats aimed at reducing fear, anxiety, and clinic-induced distress in dogs.

Product Types Covered:

• Calming Supplements
• Pheromone-Based Products
• Calming Wearables
• Calming Toys
• Topical Calming Products
• Other Calming Products

Pet Types Covered:

• Dogs
• Cats
• Other Pets

Distribution Channels Covered:

• Veterinary Clinics and Hospitals
• Pet Specialty Stores
• Supermarkets and Mass Retailers
• Online Retail
• Other Distribution Channels

Regions Covered:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • United Kingdom
  • Germany
  • France
  • Italy
  • Spain
  • Netherlands
  • Belgium
  • Sweden
  • Switzerland
  • Poland
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Malaysia
  • Singapore
  • Vietnam
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Colombia
  • Chile
  • Peru
  • Rest of South America
• Rest of the World (RoW)
  • Middle East
• Saudi Arabia
• United Arab Emirates
• Qatar
• Israel
• Rest of Middle East
  • Africa
• South Africa
• Egypt
• Morocco
• Rest of Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances